Healthtech Investors & VC Firms in United Kingdom
427 firms in this list, with a median first check of $540K. 97 of them lead rounds. Generated from verified public data and updated continuously.
Verlinvest
BrusselsSeed–Late Stage
18 people
Forepont Capital Partners
New YorkPre-Seed–Late Stage
26 people
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage$20M – $80M
18 people
Vulpes Investment Management
George TownSeed–Series A$1M – $15M
27 people
J2 Ventures
BostonPre-Seed–Series A
19 people
Ananda Impact Ventures
MunichPre-Seed–Series B$540K – $3.2M
17 people
T. Rowe Price
BaltimoreSeed–Late Stage
1 person
AV8 Ventures
Palo AltoPre-Seed–Series A$500K – $10M
12 people
Conversion Capital
San FranciscoPre-Seed–Late Stage$500K – $5M
7 people
Eurazeo
ParisSeries A–Late Stage
12 people
Galion.exe
Seed$275K – $2.8M
16 people
Astellas Venture Management LLC
South San FranciscoSeed–Growth$200K – $5M
10 people
Epidarex Capital
BethesdaPre-Seed–Series A$2.5M – $6.3M
12 people
Quantonation
ParisPre-Seed–Series B
13 people
Carbide Ventures
Palo AltoPre-Seed–Series A
9 people
Dimension Capital
San FranciscoSeed–Late Stage$1M – $10M
14 people
Keensight Capital
ParisGrowth–Late Stage$10M – $800M
5 people
Quan Capital
ShanghaiSeed–Late Stage
16 people
LAUNCHub Ventures
SofiaPre-Seed–Series A$324K – $3.2M
9 people
Onsight Ventures
InnsbruckPre-Seed–Series A$216K – $2.2M
14 people
BIOSPRING PARTNERS
New YorkGrowth–Late Stage
22 people
Noetic
TorontoSeed–Series A
13 people
ACT Venture Capital
DublinSeed–Growth$1.1M – $16.2M
11 people
Kogito Ventures
WarsawPre-Seed–Series A$125K – $750K
9 people
Related lists
Investors & VC Firms in North America (14139)Investors & VC Firms in United States (13277)Investors & VC Firms in Europe (5574)Crypto & Web3 Investors & VC Firms (4829)Investors & VC Firms in Global (4159)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3768)Fintech Investors & VC Firms (3725)Investors & VC Firms in Asia-Pacific (3573)Healthtech Investors & VC Firms (3414)
Data sourced from public filings and firms' own websites — see our methodology.





















































































